KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Hologic (HOLX) EBITDA (2016 - 2025)

Historic EBITDA for Hologic (HOLX) over the last 17 years, with Q4 2025 value amounting to $263.3 million.

  • Hologic's EBITDA rose 403.0% to $263.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $747.8 million, marking a year-over-year decrease of 2023.47%. This contributed to the annual value of $823.2 million for FY2025, which is 1616.25% down from last year.
  • As of Q4 2025, Hologic's EBITDA stood at $263.3 million, which was up 403.0% from $236.9 million recorded in Q3 2025.
  • Hologic's 5-year EBITDA high stood at $796.8 million for Q1 2021, and its period low was -$7.0 million during Q1 2025.
  • In the last 5 years, Hologic's EBITDA had a median value of $253.8 million in 2024 and averaged $289.3 million.
  • Per our database at Business Quant, Hologic's EBITDA soared by 1732857.14% in 2024 and then tumbled by 10332.7% in 2025.
  • Hologic's EBITDA (Quarter) stood at $641.3 million in 2021, then crashed by 59.08% to $262.4 million in 2022, then dropped by 24.47% to $198.2 million in 2023, then increased by 27.7% to $253.1 million in 2024, then grew by 4.03% to $263.3 million in 2025.
  • Its EBITDA was $263.3 million in Q4 2025, compared to $236.9 million in Q3 2025 and $254.6 million in Q2 2025.